In patients with enthesitis or axial disease refractory to NSAID therapy, there is little evidence for benefit with nonbiologic DMARDs, so that TNF inhibitor therapy may be warranted in this situation
All details provided on this website are for informational and educational purposes only
The trial data is striking over 20% body weight loss in some participants
Nearly all studies originate from one research group, raising concerns about independent replication
Global burden of liver disease: 2023 update
For a full overview of the peptide protocols available at our clinic, including which peptides are included, how they are combined, and what the clinical process looks like from intake to follow-up, see our comprehensive peptide treatment plan at Perfect B in Doral, FL